financetom
Business
financetom
/
Business
/
RBC Capital Markets Updates Estimates For Methanex
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Capital Markets Updates Estimates For Methanex
Apr 3, 2024 7:49 AM

10:29 AM EDT, 04/03/2024 (MT Newswires) -- RBC Capital Markets said Tuesday that it updated its model for Methanex Corp. ( MEOH ) to reflect the company's modestly higher non-discounted reference prices and CMA's most recent price forecast.

The adjusted EBITDA forecast for Methanex ( MEOH ) was raised to US$579 million from US$559 million in 2024 and to US$608 million from US$605 million in 2025.

RBC said it sees potential downside risk for Methanex ( MEOH ) if a global economic slowdown materializes in 2024, citing the company's high sensitivity to methanol prices.

RBC added that it sees near-term upside for Methanex ( MEOH ) in the event of supply disruptions in oil, gas and methanol sectors due to geopolitical events.

RBC gave Methanex ( MEOH ) a sector perform rating with a US$45.00 price target. RBC reiterated its Sector Perform rating as it sees limited catalysts that could move the shares higher as the company focuses on repairing/restarting G3 and building cash on its balance sheet ahead of a debt maturity in December 2024.

Price: 64.85, Change: +2.41, Percent Change: +3.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mullen Group Reports Renewal of Normal Course Issuer Bid
Mullen Group Reports Renewal of Normal Course Issuer Bid
Mar 7, 2024
07:39 AM EST, 03/07/2024 (MT Newswires) -- Mullen Group Ltd. ( MLLGF ) said Thursday that it has secured approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid. Under the renewed Bid, the company may buy back from time to time up to a maximum of 8.2 million shares, which represents, as at Feb....
EyePoint Pharmaceuticals' Q4 Net Loss Narrows, Revenue Advances; Shares Up Pre-Bell
EyePoint Pharmaceuticals' Q4 Net Loss Narrows, Revenue Advances; Shares Up Pre-Bell
Mar 7, 2024
07:33 AM EST, 03/07/2024 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) reported a Q4 net loss of $0.33 per diluted share, narrower than its loss of $1.16 a year earlier. Analysts polled by Capital IQ expected a loss of $0.49 per share. Revenue for the quarter ended Dec. 31 was $14 million, up from $10.5 million a year earlier....
AtriCure Insider Sold Shares Worth $307,510, According to a Recent SEC Filing
AtriCure Insider Sold Shares Worth $307,510, According to a Recent SEC Filing
Mar 7, 2024
07:34 AM EST, 03/07/2024 (MT Newswires) -- Karl S. Dahlquist, Chief Legal Officer, on March 05, 2024, sold 8,231 shares in AtriCure ( ATRC ) for $307,510. Following the Form 4 filing with the SEC, Dahlquist has control over a total of 52,839 shares of the company, with 52,839 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000040/xslF345X03/wk-form4_1709814482.xml ...
Frontier Group Holdings Insider Sold Shares Worth $2,342,753, According to a Recent SEC Filing
Frontier Group Holdings Insider Sold Shares Worth $2,342,753, According to a Recent SEC Filing
Mar 7, 2024
07:30 AM EST, 03/07/2024 (MT Newswires) -- Barry Biffle, Director, CEO, around March 04, 2024, sold 308,774 shares in Frontier Group Holdings ( ULCC ) for $2,342,753. Following the Form 4 filing with the SEC, Biffle has control over a total of 821,930 shares of the company, with 772,981 shares held directly and 48,949 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1670076/000156218024002385/xslF345X03/primarydocument.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved